openPR Logo
Press release

Global Anticancer Drugs Market Size, Share & Growth is Projected to Grow at a CAGR of 6.9% During the Forecast Period | BlueWeave

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global anticancer drugs market was worth USD 112.3 billion in the year 2020. The data yielded by the report further states that the market is estimated to grow at a CAGR of 6.9%, earning revenue of around USD 175.9 billion by the end of 2027. The global anticancer drugs market is flourishing at a high rate because of the increasing prevalence of cancer worldwide and growing research and development activities for advancing anticancer drugs. Nevertheless, the adverse side effects of the anticancer drugs may harm the market revenue up to some degree.

Browse report URL for more information about Global Anticancer Drugs Market @ https://www.blueweaveconsulting.com/report/global-anticancer-drugs-market

Increasing Adoption of Target Therapies for Cancer Treatment Is Anticipated to Boost the Global Anticancer Drugs Market

Based on the types of therapies, the global anticancer drugs market is segmented into chemotherapy, targeted therapy, and immunotherapy. The target therapy segment held the largest market share in 2020 and is likely to maintain its dominance even during the forecast period. The increasing demand for target therapy for the treatment of various types of cancer is one of the major factors driving the growth of this segment. Target therapies specifically use drugs that target genes and proteins which propagate the growth of the tumor or cancer cells. The immunotherapy segment, on the other hand, is also growing at an impressive ratedue to the launch of a wide range of medications launched in this area.

Growing Demand for Injectables Is Projected to Favorthe Global Anticancer Drugs Market

In terms of dosage forms, the global anticancer drugs market is segmented into solid dosage form, liquid dosage form, and injectable dosage form. Among these, the injectable segment leads the market and is likely to dominate even during the forecast period. This is because injectable chemotherapy is one of the most common cancer treatment methods since many types of chemotherapy are administered through injections. In many cases, the anticancer drug is injected into the body with a syringe. This segment is further classified into prefilled syringes and others. Other than the injectable segment, the solid dosage form segment is also expected to witness substantial growth during the forecast period.

Global Anticancer Drugs Market - By Distribution Channel

Based on distribution channels, the global anticancer drugs market is segmented into hospital pharmacies, retail pharmacies, online, and others. Hospital pharmacies account for the largest share of the market. This is because the high number of diagnostic tests and treatments performed at hospitals results in a high number of prescriptions for medication that can easily be obtained from the hospitals.Online pharmacies, on the other hand, are expected to gain significant traction, especially after the COVID-19 outbreak. Additionally, the online medical stores also offer great discounts in order to entice potential customers.

Browse TOC with Facts and Figures @ https://www.blueweaveconsulting.com/report/global-anticancer-drugs-market/toc

Global Anticancer Drugs Market - Regional Insights

Geographically, the global anticancer drugs market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among these regions, North America dominates the market. However, the Asia-Pacific region is estimated to witness substantial growth in the anticancer drugs market during the forecast period. The surging prevalence of cancer and the adoption of advanced medical techniques for its treatment are major factors driving the growth of the anticancer drugs market in this region. Furthermore, the government is also taking various initiatives for cancer diagnosis, and offering aid to unprivileged cancer patients, thereby contributing to the growth of the anticancer drugs market in the Asia Pacific region.

Impact of COVID-19 on Global Anticancer Drugs Market

Due to the COVID-19 situation, the global anticancer drug market initially suffered a sharp decline.The reason for this decline is because fewer patients visited hospitals to receive chemotherapy or other treatment therapies, which directly impacted the demand for anticancer drugs.The pandemic-induced lockdown, however, also led to cancer patients becoming more dependent on drugs, which increased market growth.Furthermore, the pharmaceutical companies also improved their distribution channels to meet the growing demands for anticancer drugs, which in turn led to the growth of the global anticancer drugs market.

Request For Free Sample Report @ https://www.blueweaveconsulting.com/report/global-anticancer-drugs-market/report-sample

Competitive Landscape

The leading market players in the global anticancer drugs market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Pfizer Inc., Novartis AG, Merck & Co. Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Astellas Pharma Inc., AbbVie Inc., Amgen, Takeda Oncology Drugs Ltd., GlaxoSmithKline, Sanofi, Celgene Corporation, Boehringer Ingelheim GmbH, Teva Pharmaceuticals, Eli Lilly and Company, Millennium Pharmaceuticals, Kolaz Biotech, and other prominent players.

The industry participants invest heavily in the research and development activities for product approvals and launches to stay ahead in the competition. They also offer a wide range of products to various geographical locations to expand their market revenue share. Furthermore, the adoption of competitive strategies such as partnerships, mergers, collaborations, and joint ventures have become very common in this market.

Don’t miss the business opportunity of the global anticancer drugs market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global anticancer drugs market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the global anticancer drugs market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Please find some reported topics:

https://www.blueweaveconsulting.com/report/minimally-invasive-surgical-instruments-market

https://www.blueweaveconsulting.com/report/medical-device-cleaning-market

Contact Us:

BlueWeave Consulting & Research Pvt. Ltd
US: +1 866 658 6826 | +1 425 320 4776
UK: +44 1865 60 0662
Email – info@blueweaveconsulting.com
Linked In Page: https://www.linkedin.com/company/blueweaveconsulting/

112 - H160 - BSI Business Park Sector - 63, Noida U.P. - India

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Anticancer Drugs Market Size, Share & Growth is Projected to Grow at a CAGR of 6.9% During the Forecast Period | BlueWeave here

News-ID: 2364809 • Views: 198

More Releases from BlueWeave Consulting & Research Pvt Ltd.

United States Enhanced Water Market Size, Share Growth is Projected to Growing a …
The United States enhanced water market is growing at high rate because of the rising health awareness and the need for additional nutritional supplements in the body due to a busy lifestyle.... A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the US enhanced water market was worth USD 2,131.0 million in the year 2020. The data yielded by the study reveals that the
Global Electronic Bill Presentment and Payment (EBPP) Market Size & Share is Gro …
Electronic bill presentment and payment (EBPP) market is being driven by factors such as globalization, businesses expanding overseas, and consumers increasingly using plastic money. Market growth is also driven by the use of high-speed internet access on smart phones... A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global electronic bill presentment and payment (EBPP) market was worth 18.5 number of bills in
Global Fatty Alcohol Market Size & Share is Predicted to Garner USD 8.4 Billion …
The global fatty alcohol market is growing at a high CAGR because of the increasing demand for bio-based renewable products to promote sustainability and control dependence on non-renewable products such as petrochemicals... A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global fatty alcohol market was worth USD 5.5 billion in the year 2020. The market is estimated to grow at a CAGR
Global Medical Goggle Market Size, Share & Growth is Projected to Grow at a CAGR …
The global medical goggle market is growing at a high CAGR because of the increasing demand for surgical procedures and prevalence of infectious diseases and stringent regulations regarding the safety of healthcare workers... A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global medical goggle market was worth USD 443.4 million in the year 2020. The data generated by the study reveals that

All 5 Releases


More Releases for Drugs

Acne Drugs: Global Markets
The global market for acne drugs was valued at REDACTED in 2019. The market is expected to growat a compound annualgrowth rate (CAGR) of REDACTED to reach REDACTED by 2025. Growth of the global market is attributed the increasing numberof cases of acne and skin diseases, unhealthy eating habits and the rising adoption of skin care productsworldwide. To Get Sample Copy of Report Visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=2798596 Increasing prevalence of the acne and
Acne Drugs Market
According to IMARC Group’s latest report, titled “Acne Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”. Looking forward, IMARC Group expects the global acne drugs market to continue its moderate growth during the next five years. Acne drugs are medications used to treat a dermatological infection caused by the inflammation in the hair follicles on the skin. It is generally due to hormonal imbalance, oily skin, accumulation of
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells
Tardive Dyskinesia Drugs Market
Tardive dyskinesia (TD) is a form of dyskinesia that is difficult to treat. It is a nerve disorder characterized by involuntary movements such as jaw, lips, and tongue, considered as grimacing, sticking the tongue out, and lip smacking. Some other symptoms are an individual experiencing involuntary movement of the lower and upper extremities and also breathing choking. According to Center for Drug Evaluation and Research, tardive dyskinesia can lead to